Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-105751
Filing Date
2010-11-15
Accepted
2010-11-15 16:39:41
Documents
6
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c08393e10vq.htm 10-Q 184581
2 EXHIBIT 10.18 c08393exv10w18.htm EX-10.18 92583
3 EXHIBIT 31.1 c08393exv31w1.htm EX-31.1 7795
4 EXHIBIT 31.2 c08393exv31w2.htm EX-31.2 7837
5 EXHIBIT 32.1 c08393exv32w1.htm EX-32.1 3826
6 GRAPHIC c08393c0839301.gif GRAPHIC 16662
  Complete submission text file 0000950123-10-105751.txt   321115
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 101193094
SIC: 2834 Pharmaceutical Preparations